Compile Data Set for Download or QSAR
maximum 50k data
Found 291 Enz. Inhib. hit(s) with all data for entry = 6882
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155803(US9012651, 247)
Affinity DataIC50:  80nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155784(US9012651, 223)
Affinity DataIC50:  80nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155667(US9012651, 97)
Affinity DataIC50:  110nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155664(US9012651, 94)
Affinity DataIC50:  120nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155846(US9012651, 294)
Affinity DataIC50:  120nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155826(US9012651, 273)
Affinity DataIC50:  120nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155842(US9012651, 289)
Affinity DataIC50:  130nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155669(US9012651, 99)
Affinity DataIC50:  140nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155785(US9012651, 224)
Affinity DataIC50:  140nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155789(US9012651, 228)
Affinity DataIC50:  140nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155643(US9012651, 73)
Affinity DataIC50:  140nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155802(US9012651, 246)
Affinity DataIC50:  160nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155801(US9012651, 245)
Affinity DataIC50:  160nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155800(US9012651, 244)
Affinity DataIC50:  160nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM47251(US9012651, 71)
Affinity DataIC50:  160nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155819(US9012651, 264)
Affinity DataIC50:  170nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155841(US9012651, 288)
Affinity DataIC50:  170nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM47273(US9012651, 290)
Affinity DataIC50:  170nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155822(US9012651, 267)
Affinity DataIC50:  180nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155641(US9012651, 70)
Affinity DataIC50:  180nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155820(US9012651, 265)
Affinity DataIC50:  190nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155633(US9012651, 61)
Affinity DataIC50:  190nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155591(US9012651, 17)
Affinity DataIC50:  200nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM47272(US9012651, 272)
Affinity DataIC50:  220nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155638(US9012651, 66)
Affinity DataIC50:  220nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155818(US9012651, 263)
Affinity DataIC50:  230nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155811(US9012651, 255)
Affinity DataIC50:  230nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155593(US9012651, 19)
Affinity DataIC50:  230nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155833(US9012651, 280)
Affinity DataIC50:  250nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155836(US9012651, 283)
Affinity DataIC50:  260nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155673(US9012651, 103)
Affinity DataIC50:  260nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155827(US9012651, 274)
Affinity DataIC50:  260nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155663(US9012651, 93)
Affinity DataIC50:  270nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155844(US9012651, 292)
Affinity DataIC50:  280nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155814(US9012651, 258)
Affinity DataIC50:  290nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155619(US9012651, 47)
Affinity DataIC50:  290nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155796(US9012651, 238)
Affinity DataIC50:  290nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155650(US9012651, 80)
Affinity DataIC50:  290nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155656(US9012651, 86)
Affinity DataIC50:  300nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155816(US9012651, 260)
Affinity DataIC50:  300nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155777(US9012651, 216)
Affinity DataIC50:  310nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155668(US9012651, 98)
Affinity DataIC50:  320nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155637(US9012651, 65)
Affinity DataIC50:  320nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155600(US9012651, 27)
Affinity DataIC50:  320nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155620(US9012651, 48)
Affinity DataIC50:  330nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155666(US9012651, 96)
Affinity DataIC50:  330nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155665(US9012651, 95)
Affinity DataIC50:  340nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155813(US9012651, 257)
Affinity DataIC50:  340nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155672(US9012651, 102)
Affinity DataIC50:  350nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTransient receptor potential cation channel subfamily V member 3(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM155805(US9012651, 249)
Affinity DataIC50:  350nMAssay Description:Experiments were conducted using the FLIPRTETRAŽ. On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 291 total ) | Next | Last >>
Jump to: